- Home
- PRME vs CCD Comparison
PRME vs CCD Comparison
Compare PRME & CCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- CCD
- Stock Information
- Founded
- PRME 2019
- CCD 2014
- Country
- PRME United States
- CCD United States
- Employees
- PRME N/A
- CCD N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- CCD Trusts Except Educational Religious and Charitable
- Sector
- PRME Health Care
- CCD Finance
- Exchange
- PRME Nasdaq
- CCD Nasdaq
- Market Cap
- PRME 693.5M
- CCD 555.7M
- IPO Year
- PRME 2022
- CCD N/A
- Fundamental
- Price
- PRME $5.78
- CCD $21.66
- Analyst Decision
- PRME Buy
- CCD
- Analyst Count
- PRME 6
- CCD 0
- Target Price
- PRME $8.88
- CCD N/A
- AVG Volume (30 Days)
- PRME 3.8M
- CCD 96.1K
- Earning Date
- PRME 11-11-2025
- CCD 01-01-0001
- Dividend Yield
- PRME N/A
- CCD 10.61%
- EPS Growth
- PRME N/A
- CCD N/A
- EPS
- PRME N/A
- CCD N/A
- Revenue
- PRME $4,961,000.00
- CCD N/A
- Revenue This Year
- PRME $179.58
- CCD N/A
- Revenue Next Year
- PRME N/A
- CCD N/A
- P/E Ratio
- PRME N/A
- CCD N/A
- Revenue Growth
- PRME 739.42
- CCD N/A
- 52 Week Low
- PRME $1.11
- CCD $16.93
- 52 Week High
- PRME $6.94
- CCD $24.68
- Technical
- Relative Strength Index (RSI)
- PRME 60.95
- CCD 61.79
- Support Level
- PRME $4.87
- CCD $21.00
- Resistance Level
- PRME $6.94
- CCD $21.15
- Average True Range (ATR)
- PRME 0.49
- CCD 0.36
- MACD
- PRME 0.07
- CCD 0.02
- Stochastic Oscillator
- PRME 47.88
- CCD 69.65
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About CCD Calamos Dynamic Convertible & Income Fund
Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.